A detailed history of Longbow Finance Sa transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Longbow Finance Sa holds 30,246 shares of BMY stock, worth $1.69 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
30,246
Previous 31,905 5.2%
Holding current value
$1.69 Million
Previous $1.73 Billion 27.4%
% of portfolio
0.13%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $66,774 - $87,910
-1,659 Reduced 5.2%
30,246 $1.26 Billion
Q1 2024

Apr 30, 2024

BUY
$47.98 - $54.4 $1.53 Million - $1.74 Million
31,905 New
31,905 $1.73 Billion
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $13.9 Million - $16.4 Million
202,821 New
202,821 $14.6 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Longbow Finance Sa Portfolio

Follow Longbow Finance Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Longbow Finance Sa, based on Form 13F filings with the SEC.

News

Stay updated on Longbow Finance Sa with notifications on news.